Literature DB >> 32068385

Finite-Size Charged Species Diffusion and pH Change in Nanochannels.

Nicola Di Trani1,2, Alberto Pimpinelli3, Alessandro Grattoni1,4,5.   

Abstract

Molecular transport through nanofluidic structures exhibits properties that are unique at the nanoscale. The high surface-to-volume ratio of nanometer-sized confined spaces renders particle interactions with the surface of central importance. The electrical double layer (EDL) at the solid-liquid interface of charged surfaces generates an enrichment of counterions and the exclusion of co-ions that lead to a change in their diffusivity. In addition, the diffusive transport is altered by steric and hydrodynamic interactions between fluid molecules and the boundaries. An extensive body of literature investigates molecular transport at the nanoscale. However, most studies account for ionic species as point charges, severely limiting the applicability of the results to "large" nanofluidic systems. Moreover, and even more importantly, the change of pH in the nanoconfined region inside nanochannels has been completely overlooked. Corroborated by experimental data, here we present an all-encompassing analysis of molecular diffusion from the micro- to the ultra-nanoscale. While accounting for finite-size ions, we compute self-consistently the pH inside the channels. Surprisingly, we found that the concentration of ions H+ can change by more than 2 orders of magnitude compared to the bulk, hugely affecting molecular transport. Further, we found that counterions exhibit both enrichment and exclusion, depending on the size of nanochannels. Achieving a greater understanding of the effective transport properties of fluids at the nanoscale will fill the gap in knowledge that still limits development of innovative systems for medicine and industrial applications alike.

Keywords:  drug delivery; electric double layer; enrichment/exclusion effect; finite ion size; hindered transport; nanoscale diffusion

Year:  2020        PMID: 32068385     DOI: 10.1021/acsami.9b19182

Source DB:  PubMed          Journal:  ACS Appl Mater Interfaces        ISSN: 1944-8244            Impact factor:   9.229


  8 in total

1.  Trans-urocanic acid enhances tenofovir alafenamide stability for long-acting HIV applications.

Authors:  Antons Sizovs; Fernanda P Pons-Faudoa; Gulsah Malgir; Kathryn A Shelton; Lane R Bushman; Corrine Ying Xuan Chua; Peter L Anderson; Pramod N Nehete; K Jagannadha Sastry; Alessandro Grattoni
Journal:  Int J Pharm       Date:  2020-07-11       Impact factor: 5.875

2.  Extending drug release from implants via transcutaneous refilling with solid therapeutics.

Authors:  Nicola Di Trani; Fernanda P Pons-Faudoa; Antons Sizovs; Kathryn A Shelton; Mark A Marzinke; Pramod N Nehete; Alessandro Grattoni
Journal:  Adv Ther (Weinh)       Date:  2021-12-26

3.  Preventive efficacy of a tenofovir alafenamide fumarate nanofluidic implant in SHIV-challenged nonhuman primates.

Authors:  Fernanda P Pons-Faudoa; Antons Sizovs; Kathryn A Shelton; Zoha Momin; Jean A Niles; Lane R Bushman; Jiaqiong Xu; Corrine Ying Xuan Chua; Joan E Nichols; Sandra Demaria; Michael M Ittmann; Trevor Hawkins; James F Rooney; Mark A Marzinke; Jason T Kimata; Peter L Anderson; Pramod N Nehete; Roberto C Arduino; Mauro Ferrari; K Jagannadha Sastry; Alessandro Grattoni
Journal:  Adv Ther (Weinh)       Date:  2020-12-16

Review 4.  Tenofovir Alafenamide for HIV Prevention: Review of the Proceedings from the Gates Foundation Long-Acting TAF Product Development Meeting.

Authors:  Joseph W Romano; Marc M Baum; Zach R Demkovich; Frank Diana; Charles Dobard; Paul L Feldman; J Gerardo Garcia-Lerma; Alessandro Grattoni; Manjula Gunawardana; Duy-Khiet Ho; Thomas J Hope; Ivana Massud; Mark Milad; John A Moss; Fernanda P Pons-Faudoa; Shane Roller; Ariane van der Straten; Selvi Srinivasan; Ronald S Veazey; Doris Zane
Journal:  AIDS Res Hum Retroviruses       Date:  2021-06       Impact factor: 2.205

5.  Potentiating Antitumor Efficacy Through Radiation and Sustained Intratumoral Delivery of Anti-CD40 and Anti-PDL1.

Authors:  Hsuan-Chen Liu; Dixita I Viswanath; Federica Pesaresi; Yitian Xu; Licheng Zhang; Nicola Di Trani; Jesus Paez-Mayorga; Nathanael Hernandez; Yu Wang; Donald R Erm; Jeremy Ho; Antonia Susnjar; Xuewu Liu; Sandra Demaria; Shu-Hsia Chen; Bin S Teh; Edward Brian Butler; Corrine Ying Xuan Chua; Alessandro Grattoni
Journal:  Int J Radiat Oncol Biol Phys       Date:  2020-08-05       Impact factor: 8.013

6.  Electrostatically gated nanofluidic membrane for ultra-low power controlled drug delivery.

Authors:  Nicola Di Trani; Antonia Silvestri; Antons Sizovs; Yu Wang; Donald R Erm; Danilo Demarchi; Xuewu Liu; Alessandro Grattoni
Journal:  Lab Chip       Date:  2020-05-05       Impact factor: 6.799

7.  Long-acting tunable release of amlodipine loaded PEG-PCL micelles for tailored treatment of chronic hypertension.

Authors:  Nicola Di Trani; Hsuan-Chen Liu; Ruogu Qi; Dixita I Viswanath; Xuewu Liu; Corrine Ying Xuan Chua; Alessandro Grattoni
Journal:  Nanomedicine       Date:  2021-06-22       Impact factor: 6.096

8.  Viral load Reduction in SHIV-Positive Nonhuman Primates via Long-Acting Subcutaneous Tenofovir Alafenamide Fumarate Release from a Nanofluidic Implant.

Authors:  Fernanda P Pons-Faudoa; Nicola Di Trani; Antons Sizovs; Kathryn A Shelton; Zoha Momin; Lane R Bushman; Jiaqiong Xu; Dorothy E Lewis; Sandra Demaria; Trevor Hawkins; James F Rooney; Mark A Marzinke; Jason T Kimata; Peter L Anderson; Pramod N Nehete; Roberto C Arduino; K Jagannadha Sastry; Alessandro Grattoni
Journal:  Pharmaceutics       Date:  2020-10-17       Impact factor: 6.525

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.